Weak linkage at 4p16 to predisposition for human neuroblastoma.
The most frequent genetic alterations described in neuroblastoma (NB) are amplification of MYCN oncogene and deletion of chromosome 1p, although somatic deletions have been demonstrated at other chromosomal intervals. Since loss of heterozygosity (LOH) at distal 4p has been observed in about 20-29% of neuroblastomas, we have evaluated deletions in 41 Italian NB samples by LOH analysis at loci mapping to 4p as follows: pter-D4S2936-D4S412-D4S2957-D4S432-D4S3023-D4S431-cen. Our analysis showed allele losses in eight out of 41 samples (19.5%) and allowed the identification of a smallest region of overlapping deletion (SRO) of 3.0 cM, delimited by D4S412 and D4S3023. Two of these tumors with 4p LOH are from patients belonging to a family with recurrent NB. Interestingly the genotyping of this family revealed an identical haplotype that includes the nonrecombinant loci D4S412, D4S2957 and D4S432 shared by all affected children and demonstrated that this haplotype is retained in the two tumors carrying somatic deletions from patients of this family. Furthermore linkage analysis was performed in two NB families and yielded an overall lod-score of 3.0 in the interval including the haplotype. This provides a confirmatory indication that the region delimited by D4S2936 and D4S3023, which also includes the new defined SRO, may harbor NB predisposing gene/s.
Perri
Patrizia
P
Laboratory of Neuroblastoma Research, Advanced Biotechnology Center, 16132 Genoa, Italy.
Longo
Luca
L
Cusano
Roberto
R
McConville
Carmel M
CM
Rees
Sally A
SA
Devoto
Marcella
M
Conte
Massimo
M
Ferrara
Giovanni Battista
GB
Seri
Marco
M
Romeo
Giovanni
G
Tonini
Gian Paolo
GP
D002648:Child; D002894:Chromosomes, Human, Pair 4; D005260:Female; D008040:Genetic Linkage; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D019656:Loss of Heterozygosity; D008297:Male; D009447:Neuroblastoma / Q000235:genetics*; D010375:Pedigree